The gastric pentdecapeptide BPC-157 is an anti-ulcer peptide, stable agent, derived from human gastric juice  which plays a role in treating inflammatory bowel syndrome, wound healing and having stability in human gastric juice . In addition, BPC-157 has been shown to be an effective treatment in clinical trials for inflammatory bowel syndrome . Moreover, BPC-157 has been previously shown to harbour anti-anti-inflammatory and wound healing effects in a range of tissues and organs . In addition to these benefits in the human body, BPC-157 is known to reduce the production of reactive oxygen species (ROS) .
How it works
BPC-157 contains the partial sequence of the body protection compound (BPC) which has been isolated from human gastric juice . Moreover, BPC-157 is resistant to the effects of hydrolysis, or ‘degradation’, by various enzymes . BPC-157 has the amino acid sequence of: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, and has been tested in animals for cryoprotection and wound healing.
Figure 1. BPC-157 is a 15-amino acid sequence peptide which has a wide range of protective actions in various experiments conditions and models . In addition, this peptide is considered synthetic as it does not occur in nature.